(Q44388508)

2 December 2017

Accelerated clearance of a second injection of PEGylated liposomes in mice (English)

1 reference

2 December 2017

Tatsuhiro Ishida

1

1 reference

2 December 2017

Kaori Masuda

2

1 reference

2 December 2017

Takako Ichikawa

3

1 reference

2 December 2017

Masako Ichihara

4

1 reference

2 December 2017

Kenji Irimura

5

1 reference

2 December 2017

Hiroshi Kiwada

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

International Journal of Pharmaceutics

2 December 2017

1 reference

2 December 2017

255

1 reference

2 December 2017

1-2

1 reference

2 December 2017

167-174

1 reference

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Kinetic modeling of liposome degradation in blood circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Fatal hepatic failure with liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Accelerated clearance of PEGylated liposomes in rats after repeated injections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900085-1

7 January 2021

10.1016/S0378-5173(03)00085-1

Identifiers

DOI

1 reference

2 December 2017

1 reference